DeepMed Research

McGill University

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1821-01-01

Employees: 10K

Market Cap: -

Website: http://www.mcgill.ca

Clinical Trials

Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal Adenocarcinoma

Phase 2

Completed

Conditions: Esophageal Adenocarcinoma
Gastric Adenocarcinoma

Interventions: Drug: FLOT (5-fluorouracil, oxaliplatin, docetaxel)

First Posted Date: 2013-08-30

Last Posted Date: 2015-10-27

Lead Sponsor: McGill University

Target Recruit Count: 10

Registration Number: NCT01932580

Locations: 🇨🇦
Montreal General Hospital, Montreal, Quebec, Canada

Effectiveness of Parenting Programs on Child Development and Maternal Well-being in Rural Uganda

Not Applicable

Completed

Conditions: Child Development
Depression

Interventions: Behavioral: Parenting Program

First Posted Date: 2013-07-24

Last Posted Date: 2016-03-18

Lead Sponsor: McGill University

Target Recruit Count: 360

Registration Number: NCT01906606

Locations: 🇺🇬
Lira Program Unit, Plan Uganda, Lira, Uganda

Inhaled Fentanyl Citrate & Dyspnea

Early Phase 1

Completed

Conditions: Dyspnea

Interventions: Drug: Fentanyl Citrate
Other: CWS
Drug: Placebo

First Posted Date: 2013-05-15

Last Posted Date: 2017-02-14

Lead Sponsor: McGill University

Target Recruit Count: 14

Registration Number: NCT01853449

Locations: 🇨🇦
Montreal Chest Institute; McGill University Health Center & McGill University, Montreal, Quebec, Canada

Inhaled Nebulized Furosemide & Physical Activity-Related Breathlessness

Phase 1

Conditions: Breathlessness

Interventions: Other: CWS
Drug: Placebo
Drug: Furosemide

First Posted Date: 2013-05-13

Last Posted Date: 2017-02-14

Lead Sponsor: McGill University

Target Recruit Count: 30

Registration Number: NCT01851980

Locations: 🇨🇦
Centre of Innovative Medicine of the McGill University Health Centre, Montreal, Quebec, Canada

Inhaled Ondansetron & Dyspnea

Early Phase 1

Completed

Conditions: Dyspnea

Interventions: Drug: Placebo
Drug: Ondansetron

First Posted Date: 2013-05-13

Last Posted Date: 2015-08-26

Lead Sponsor: McGill University

Target Recruit Count: 30

Registration Number: NCT01851993

Locations: 🇨🇦
Clinical Exercise & Respiratory Physiology Laboratory (CERPL) of McGill University, Montreal, Quebec, Canada

Abdominal Binding in Chronic Obstructive Pulmonary Disease

Not Applicable

Completed

Conditions: Chronic Obstructive Pulmonary Disease
Dyspnea

Interventions: Device: Abdominal Binder

First Posted Date: 2013-05-13

Last Posted Date: 2015-08-26

Lead Sponsor: McGill University

Target Recruit Count: 20

Registration Number: NCT01852006

Locations: 🇨🇦
Montreal Chest Institute; McGill University Health Center & McGill University, Montreal, Quebec, Canada

Local Endometrial Injury in Fresh Embryo Transfer Cycles

Phase 3

Conditions: Infertility

Interventions: Procedure: Endometrial Biopsy

First Posted Date: 2013-05-01

Last Posted Date: 2013-05-01

Lead Sponsor: McGill University

Target Recruit Count: 360

Registration Number: NCT01844453

Locations: 🇨🇦
McGill University Health Centre, Montreal, Quebec, Canada

Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study

Phase 4

Completed

Conditions: Human Papillomavirus Infection

Interventions: Biological: Hepatitis A vaccine
Biological: HPV vaccine, Gardasil 9

First Posted Date: 2013-04-04

Last Posted Date: 2025-03-19

Lead Sponsor: McGill University

Target Recruit Count: 372

Registration Number: NCT01824537

Locations: 🇨🇦
McGill University - Division of Cancer Epidemiology, Montreal, Quebec, Canada

A Randomized Controlled Trial of a Robotic Simulation Curriculum to Teach Robotic Suturing

Not Applicable

Completed

Conditions: Neoplasms

Interventions: Other: Training

First Posted Date: 2013-03-14

Last Posted Date: 2013-09-12

Lead Sponsor: McGill University

Target Recruit Count: 27

Registration Number: NCT01811095

Locations: 🇨🇦
Jewish General Hospital, Montreal, Quebec, Canada
🇨🇦
Royal Victoria Hospital, Montreal, Quebec, Canada

Sleep Apnea in Multiple Sclerosis Positive Airway Pressure Trial

Not Applicable

Completed

Conditions: Obstructive Sleep Apnea-hypopnea in Multiple Sclerosis Patients

Interventions: Device: Sham continuous positive airway pressure (CPAP)
Device: Effective continuous positive airway pressure (CPAP)

First Posted Date: 2012-12-10

Last Posted Date: 2019-01-11

Lead Sponsor: McGill University

Target Recruit Count: 49

Registration Number: NCT01746342

Locations: 🇨🇦
McGill University Health Centre, Montreal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy